Source Natural Foods and Herbal Supplements Ltd.
Snapshot View

155.60 -8.15 ▼-5.0%

30 January 2023, 04:01:00 PM
Volume: 133

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.source_natural.com
Market Cap 100.16 Cr.
Enterprise Value(EV) 101.00 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.44 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 45.20 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 25.41 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.12 Calculated using Price: 155.60
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.64 Cr. 6,436,931 Shares
FaceValue 10
Company Profile
Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.98%
1 Week
+2.33%
1 Month
+25.33%
3 Month
-0.26%
6 Month
+52.77%
1 Year
+37.70%
2 Year
+10.16%
5 Year
+29.94%
10 Year
+1125.20%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.86 3.86 8.31 22.42 10.87 12.40 17.65 29.40 16.92
Return on Capital Employed (%) 3.56 3.22 8.94 20.40 11.67 13.56 20.89 33.08 26.23
Return on Assets (%) 3.30 2.75 6.76 15.73 7.31 9.84 14.60 24.11 14.11

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5 5 6 7 8 9 10 13 16 16
Non Curr. Liab. 0 0 0 0 0 0 0 -1 0 0
Curr. Liab. 0 1 1 4 3 2 3 4 3 3
Minority Int.
Equity & Liab. 6 6 7 11 11 10 12 16 19 20
Non Curr. Assets 4 4 3 4 4 4 4 5 7 7
Curr. Assets 2 2 3 8 7 6 9 11 12 13
Misc. Exp. not W/O
Total Assets 6 6 7 11 11 10 12 16 19 20

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 5 7 11 16 11 13 14 25 22 17
Other Income 0 0 0 0 0 0 0 0
Total Income 5 7 11 16 11 13 14 25 22 18
Total Expenditure -4 -6 -10 -14 -9 -11 -11 -21 -18 -14
PBIDT 0 1 1 2 1 2 2 5 4 3
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 -1 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 -1 -1
Exceptional Items 0
PAT 0 0 0 1 1 1 2 3 2 2
Adjusted EPS 0 0 1 2 1 2 3 5 4 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 -1 0 3 0 4
Cash Fr. Inv. 0 -1 0 0 -2 0 0 -1 -2
Cash Fr. Finan. 0 0 0 0 2 0 -2 0 0
Net Change 0 0 0 0 -1 0 1 -1 3
Cash & Cash Eqvt 1 0 1 1 0 0 1 0 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37
Public 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 07 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
With reference to the captioned subject and in compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (LODR) Regulations 2015 this is to inform you that Mrs. Sweta Gaur has tendered her resignation from the post of Company Secretary (KMP) of the Company w.e.f. 07th January 2023 (after the closing of business hours) for personal reasons and the same has been taken on record by the Board of Directors in the Board Meeting Held on 19th December 2022.
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In accordance with regulation 74(5) SEBI Depositories and Participants) Regulations 2018 for the quarter ended December 2022 based on the certificate received from Venture Capital and corporate Investment Private Limited (RTA) which is enclosed herewith we hereby confirmed that no securities have received for dematerialisation/rematerialisation during the quarter 01.10.2022 to 31.12.2022 for our company.
Wed, 04 Jan 2023
Announcement Under Regulation 30
This is in reference to your email dated January 03 2023 having reference no. L/SURV/ONL/PV/KS/ 2022-2023 / 2932. We wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and has not withheld any material information/event that in our opinion would have bearing on the price behaviour of the scrip. The Company shall continue to make applicable disclosures within the stipulated time.Therefore the movement in the share price of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such movement in price.

Technical Scans View Details >>

Mon, 30 Jan 2023
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
Closing Near 100 SMA Closing Near 100 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Source Natural Foods and Herbal Supplements Ltd.

What is Source Natural Foods share price?

Can I buy Source Natural Foods shares now?

What is the Market Cap of Source Natural Foods?

What are the key metrics to analyse Source Natural Foods?

What is the 52 Week High and Low of Source Natural Foods?

What is the trend of Source Natural Foods share price?